Researcher
Leonard Guarente
Last updated Sun May 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Background
Leonard (Lenny) Guarente is Novartis Professor of Biology at MIT. Together with then-postdoc Shin-ichiro Imai and others, he showed in 2000 that yeast Sir2 is an NAD+-dependent histone deacetylase — linking metabolism (via NAD+) to chromatin and longevity.
Key contributions
- Discovery of the NAD+-dependent deacetylase activity of Sir2 (the founding member of the sirtuin family).
- Demonstrated that Sir2 overexpression extends yeast lifespan.
- Trained much of the next generation of sirtuin/longevity researchers, including David Sinclair and Matt Kaeberlein.
- Co-founded Elysium Health, a direct-to-consumer NAD+-precursor supplement company.
Influence
Guarente’s sirtuin work converted “aging” into a tractable biochemical target and established the NAD+-sirtuin axis as a central node of modern longevity research. Whether sirtuin-activating compounds reliably extend mammalian lifespan remains debated; the underlying biology is fundamental.
Related entries
References
- Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795–800 (2000).